Valiant Laboratories Operational Benchmarking
₹120.94-1.84%close, 9 Oct 2026
- Market cap
- ₹657 crore
- P/E
- 22.5
- P/B
- 2.85
- ROE
- 14.5%
- Dividend yield
- 1.20%
- 52-week range
- ₹87.08 – ₹163.27
Valiant Laboratories compared with sector peers on revenue, market capitalization, valuation, and return metrics.
Valiant Laboratories sector benchmarking & peer comparison
Operational and financial KPI comparison against sector peers.
| Company | LTP (₹) | P/E | Market Cap (₹ cr) | Div Yield | Qtr Sales (₹ cr) | ROCE % |
|---|---|---|---|---|---|---|
| Valiant Laboratories Limited | ₹120.94 | 22.5 | 657 | 1.2% | 164 | 14.5% |
| Median (1 Cos) | ₹120.94 | 22.5 | 657 | 1.2% | 164 | 14.5% |
Source: NSE sector index filings and financial statements. Data as of 9 October 2026. How this data is compiled.
Same Data For Peers
- Ventive Hospitality Limited operational benchmarking
- Vaishali Pharma Limited operational benchmarking
- Venus Remedies Limited operational benchmarking
- Unichem Laboratories Limited operational benchmarking
- Vijaya Diagnostic Centre Limited operational benchmarking
- TTK Healthcare Limited operational benchmarking
Trade Valiant Laboratories With ATS
Track VALIANTLAB live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.